13FPulse 13FPulse
中
More

Explore

Research

AL

ALLO ALLOGENE THERAPEUTICS INC

2026Q2 · CUSIP 019770106 · Sector: Healthcare & Biotech

Cooling

Net holder growth weakened from last quarter

Funds that own it
209
Institutions that reported holding it to the SEC
Net increase in holders
+1
Last quarter 208 → now 209
How unusual is that
Below average
Stronger than only 33% of US stocks
What the filings say, in one paragraph

209 funds held ALLO at the end of 2026Q2, up 1 from the quarter before. Buying has come off its highs, but funds are not exiting. On the business itself, return on equity is -37.9%. ALLO has had 5 buying rushes in its history, and the price moved -10.4% on average over the six months after (that is the raw price move, not how much it beat the market by). It sits in the Healthcare & Biotech sector.

How many funds owned it, quarter by quarter

Bars = net change in institutional holders, positive (green) or negative (red). Line = total institutional holders.

2019Q1: holders=85 2019Q2: holders=92 2019Q3: holders=94 2019Q4: holders=115 2020Q1: holders=114 2020Q2: holders=172 2020Q3: holders=160 2020Q4: holders=164 2021Q1: holders=168 2021Q2: holders=182 2021Q3: holders=169 2021Q4: holders=176 2022Q1: holders=178 2022Q2: holders=160 2022Q3: holders=191 2022Q4: holders=168 2023Q1: holders=175 2023Q2: holders=171 2023Q3: holders=155 2023Q4: holders=170 2024Q1: holders=160 2024Q2: holders=175 2024Q3: holders=156 2024Q4: holders=174 2025Q1: holders=171 2025Q2: holders=160 2025Q3: holders=172 2025Q4: holders=172 2026Q1: holders=208 2026Q2: holders=209 -58 -29 +0 +29 +58 76148220 19Q119Q420Q321Q222Q122Q423Q324Q225Q125Q426Q2 Net change in holders (bars) Total funds holding (line)

What happened after each past buying rush 5 times in its history

Quarter of the rush How unusual then Price, next 3 months Price, next 6 months
2026Q1 Top 10% +4.6% —
2024Q2 Top 20% +7.4% +13.5%
2022Q3 Top 5% -25.7% -37.3%
2020Q2 Top 5% -17.7% -10.3%
2019Q2 Top 20% +3.3% -7.7%

These are the raw price moves, not how much it beat the market by. Compare them against the market over the same months — in a strong bull market almost everything is up.

Show all the numbers (large funds, value held, options…) ▾
Of them, large funds
108
Change in large funds
+4
Total value they hold
$652M
Funds buying for the first time
33
Funds that sold out entirely
32
Price change that quarter
+7.2%
Funds holding puts (bearish)
3
Funds holding calls (bullish)
4

These are for people who want to dig. Skip them if they do not mean anything to you — the three numbers above are enough.

Fundamentals

PE (TTM)
—
EPS (TTM)
$-0.67
EPS YoY
—
Revenue (TTM)
—
Revenue YoY
—
Net margin
—
ROE
-37.9%
Debt ratio
20.7%
FCF (TTM)
-$103M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS
2021-09-30: EPS -0.57 2021-12-31: EPS 0.01 2022-03-31: EPS -0.56 2022-06-30: EPS -0.56 2022-09-30: EPS -0.59 2022-12-31: EPS -0.67 2023-03-31: EPS -0.69 2023-06-30: EPS -0.54 2023-09-30: EPS -0.37 2023-12-31: EPS -0.49 2024-03-31: EPS -0.38 2024-06-30: EPS -0.35 2024-09-30: EPS -0.32 2024-12-31: EPS -0.27 2025-03-31: EPS -0.28 2025-06-30: EPS -0.23 2025-09-30: EPS -0.19 2025-12-31: EPS -0.17 2026-03-31: EPS -0.18 2026-06-30: EPS -0.13 -0.76 -0.37 0.01 20212022202320242025202606/26 EPS

Quarterly figures, revenue up to 10 years back; EPS split-adjusted, early quarters hidden when not calibrable

Quarterly free cash flow
-70M-35M0K 201820192020202120222023202420252026
Latest quarter $-13M (2026-03-31)

FCF = operating cash flow − capex, computed from SEC XBRL; banks/insurers have no standard cash-flow structure and are hidden

As of 2026-06-30 · SEC filings (XBRL)

Email me the next update

2026 Q3 holdings are due 2026-11-16. We will email you when the refreshed lists are live.